1-(3,4-dihydro-2H-imidazo[5,1-b][1,3]oxazin-8-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydroimidazo[5,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydropyrrolo[2,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-triazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-5,6-dihydrofuro[3,2-c]pyrazol-3-yl)sulfonyl]urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-6,7-dihydro-5H-pyrano[3,2-c]pyrazol-3-yl)sulfonyl]urea

C132H152N28O28S7 — CID 159714508

About 1-(3,4-dihydro-2H-imidazo[5,1-b][1,3]oxazin-8-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydroimidazo[5,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydropyrrolo[2,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-triazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-5,6-dihydrofuro[3,2-c]pyrazol-3-yl)sulfonyl]urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-6,7-dihydro-5H-pyrano[3,2-c]pyrazol-3-yl)sulfonyl]urea

1-(3,4-dihydro-2H-imidazo[5,1-b][1,3]oxazin-8-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydroimidazo[5,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydropyrrolo[2,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-triazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-5,6-dihydrofuro[3,2-c]pyrazol-3-yl)sulfonyl]urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-6,7-dihydro-5H-pyrano[3,2-c]pyrazol-3-yl)sulfonyl]urea (PubChem CID 159714508) has the molecular formula C132H152N28O28S7 and a molecular weight of 2803.30 g/mol. Its IUPAC name is 1-(3,4-dihydro-2H-imidazo[5,1-b][1,3]oxazin-8-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydroimidazo[5,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydropyrrolo[2,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-triazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-5,6-dihydrofuro[3,2-c]pyrazol-3-yl)sulfonyl]urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-6,7-dihydro-5H-pyrano[3,2-c]pyrazol-3-yl)sulfonyl]urea.

Molecular Properties

• Compound Name: 1-(3,4-dihydro-2H-imidazo[5,1-b][1,3]oxazin-8-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydroimidazo[5,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydropyrrolo[2,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-triazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-5,6-dihydrofuro[3,2-c]pyrazol-3-yl)sulfonyl]urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-6,7-dihydro-5H-pyrano[3,2-c]pyrazol-3-yl)sulfonyl]urea
• PubChem CID: 159714508
• Molecular Formula: C132H152N28O28S7
• Molecular Weight: 2803.30 g/mol
• Exact Mass: 2800.94
• IUPAC Name: 1-(3,4-dihydro-2H-imidazo[5,1-b][1,3]oxazin-8-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydroimidazo[5,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydropyrrolo[2,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-triazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-5,6-dihydrofuro[3,2-c]pyrazol-3-yl)sulfonyl]urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-6,7-dihydro-5H-pyrano[3,2-c]pyrazol-3-yl)sulfonyl]urea
• SMILES: Cn1nc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c2c1CCCO2.Cn1nc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c2c1CCO2.O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1ccn2c1OCC2.O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1cnn2c1OCCC2.O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1ncn2c1OCC2.O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1ncn2c1OCCC2.O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1nnn2c1OCCC2
• InChI: InChI=1S/C20H24N4O4S.3C19H22N4O4S.C19H21N3O4S.C18H21N5O4S.C18H20N4O4S/c1-24-16-9-4-10-28-18(16)19(22-24)29(26,27)23-20(25)21-17-14-7-2-5-12(14)11-13-6-3-8-15(13)17;1-23-15-8-9-27-17(15)18(21-23)28(25,26)22-19(24)20-16-13-6-2-4-11(13)10-12-5-3-7-14(12)16;24-19(22-28(25,26)17-18-23(11-20-17)8-3-9-27-18)21-16-14-6-1-4-12(14)10-13-5-2-7-15(13)16;24-19(22-28(25,26)16-11-20-23-8-3-9-27-18(16)23)21-17-14-6-1-4-12(14)10-13-5-2-7-15(13)17;23-19(21-27(24,25)16-7-8-22-9-10-26-18(16)22)20-17-14-5-1-3-12(14)11-13-4-2-6-15(13)17;24-18(21-28(25,26)16-17-23(22-20-16)8-3-9-27-17)19-15-13-6-1-4-11(13)10-12-5-2-7-14(12)15;23-18(21-27(24,25)16-17-22(10-19-16)7-8-26-17)20-15-13-5-1-3-11(13)9-12-4-2-6-14(12)15/h11H,2-10H2,1H3,(H2,21,23,25);10H,2-9H2,1H3,(H2,20,22,24);2*10-11H,1-9H2,(H2,21,22,24);7-8,11H,1-6,9-10H2,(H2,20,21,23);10H,1-9H2,(H2,19,21,24);9-10H,1-8H2,(H2,20,21,23)
• InChIKey: MZGIWSAHDWLOCU-UHFFFAOYSA-N
• XLogP: 14.06
• TPSA: 716.24 Ų
• H-Bond Donors: 14
• H-Bond Acceptors: 42
• Rotatable Bonds: 21
• Heavy Atoms: 195
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2803.30
LogP ≤ 5	14.06
H-Bond Donors ≤ 5	14
H-Bond Acceptors ≤ 10	42

Frequently Asked Questions

What is the IUPAC name of 1-(3,4-dihydro-2H-imidazo[5,1-b][1,3]oxazin-8-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydroimidazo[5,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydropyrrolo[2,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-triazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-5,6-dihydrofuro[3,2-c]pyrazol-3-yl)sulfonyl]urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-6,7-dihydro-5H-pyrano[3,2-c]pyrazol-3-yl)sulfonyl]urea?

The IUPAC name of 1-(3,4-dihydro-2H-imidazo[5,1-b][1,3]oxazin-8-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydroimidazo[5,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydropyrrolo[2,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-triazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-5,6-dihydrofuro[3,2-c]pyrazol-3-yl)sulfonyl]urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-6,7-dihydro-5H-pyrano[3,2-c]pyrazol-3-yl)sulfonyl]urea (CID 159714508) is 1-(3,4-dihydro-2H-imidazo[5,1-b][1,3]oxazin-8-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydroimidazo[5,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydropyrrolo[2,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-triazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-5,6-dihydrofuro[3,2-c]pyrazol-3-yl)sulfonyl]urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-6,7-dihydro-5H-pyrano[3,2-c]pyrazol-3-yl)sulfonyl]urea.

What is the SMILES notation for 1-(3,4-dihydro-2H-imidazo[5,1-b][1,3]oxazin-8-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydroimidazo[5,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydropyrrolo[2,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-triazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-5,6-dihydrofuro[3,2-c]pyrazol-3-yl)sulfonyl]urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-6,7-dihydro-5H-pyrano[3,2-c]pyrazol-3-yl)sulfonyl]urea?

The canonical SMILES for 1-(3,4-dihydro-2H-imidazo[5,1-b][1,3]oxazin-8-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydroimidazo[5,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydropyrrolo[2,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-triazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-5,6-dihydrofuro[3,2-c]pyrazol-3-yl)sulfonyl]urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-6,7-dihydro-5H-pyrano[3,2-c]pyrazol-3-yl)sulfonyl]urea is Cn1nc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c2c1CCCO2.Cn1nc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c2c1CCO2.O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1ccn2c1OCC2.O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1cnn2c1OCCC2.O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1ncn2c1OCC2.O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1ncn2c1OCCC2.O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)c1nnn2c1OCCC2.

What is the InChIKey of 1-(3,4-dihydro-2H-imidazo[5,1-b][1,3]oxazin-8-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydroimidazo[5,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydropyrrolo[2,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-triazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-5,6-dihydrofuro[3,2-c]pyrazol-3-yl)sulfonyl]urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-6,7-dihydro-5H-pyrano[3,2-c]pyrazol-3-yl)sulfonyl]urea?

The InChIKey is MZGIWSAHDWLOCU-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H24N4O4S.3C19H22N4O4S.C19H21N3O4S.C18H21N5O4S.C18H20N4O4S/c1-24-16-9-4-10-28-18(16)19(22-24)29(26,27)23-20(25)21-17-14-7-2-5-12(14)11-13-6-3-8-15(13)17;1-23-15-8-9-27-17(15)18(21-23)28(25,26)22-19(24)20-16-13-6-2-4-11(13)10-12-5-3-7-14(12)16;24-19(22-28(25,26)17-18-23(11-20-17)8-3-9-27-18)21-16-14-6-1-4-12(14)10-13-5-2-7-15(13)16;24-19(22-28(25,26)16-11-20-23-8-3-9-27-18(16)23)21-17-14-6-1-4-12(14)10-13-5-2-7-15(13)17;23-19(21-27(24,25)16-7-8-22-9-10-26-18(16)22)20-17-14-5-1-3-12(14)11-13-4-2-6-15(13)17;24-18(21-28(25,26)16-17-23(22-20-16)8-3-9-27-17)19-15-13-6-1-4-11(13)10-12-5-2-7-14(12)15;23-18(21-27(24,25)16-17-22(10-19-16)7-8-26-17)20-15-13-5-1-3-11(13)9-12-4-2-6-14(12)15/h11H,2-10H2,1H3,(H2,21,23,25);10H,2-9H2,1H3,(H2,20,22,24);2*10-11H,1-9H2,(H2,21,22,24);7-8,11H,1-6,9-10H2,(H2,20,21,23);10H,1-9H2,(H2,19,21,24);9-10H,1-8H2,(H2,20,21,23).

What are the key properties of 1-(3,4-dihydro-2H-imidazo[5,1-b][1,3]oxazin-8-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydroimidazo[5,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydropyrrolo[2,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-triazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-5,6-dihydrofuro[3,2-c]pyrazol-3-yl)sulfonyl]urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-6,7-dihydro-5H-pyrano[3,2-c]pyrazol-3-yl)sulfonyl]urea?

1-(3,4-dihydro-2H-imidazo[5,1-b][1,3]oxazin-8-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydroimidazo[5,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydropyrrolo[2,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-triazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-5,6-dihydrofuro[3,2-c]pyrazol-3-yl)sulfonyl]urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-6,7-dihydro-5H-pyrano[3,2-c]pyrazol-3-yl)sulfonyl]urea has a molecular weight of 2803.30 g/mol, XLogP of 14.06, 21 rotatable bonds, 14 hydrogen bond donors, and 42 hydrogen bond acceptors.

Where does this data come from?

All data for 1-(3,4-dihydro-2H-imidazo[5,1-b][1,3]oxazin-8-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydroimidazo[5,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(2,3-dihydropyrrolo[2,1-b][1,3]oxazol-7-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(6,7-dihydro-5H-triazolo[5,1-b][1,3]oxazin-3-ylsulfonyl)-3-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-5,6-dihydrofuro[3,2-c]pyrazol-3-yl)sulfonyl]urea;1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-[(1-methyl-6,7-dihydro-5H-pyrano[3,2-c]pyrazol-3-yl)sulfonyl]urea is sourced from PubChem (CID 159714508), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).